Are beta blockers new potential anticancer agents?

18Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

β-Blockers have been one of the most widely used and versatile drugs for the past half a century. A new potential for their use as anti-cancer drugs has emerged in the past few years. Various retrospective case control studies have been suggestive that use of β-blockers before the diagnosis of cancer could have preventive and protective effects against non-small cell lung carcinoma, melanoma, and breast, pancreatic and prostate cancers. Experimental and clinical observations are still inconclusive with some inconsistent findings. However, indications are pointing toward a positive role of some β-blockers against certain forms of cancers. This mini review is an effort to present the up to date published results of case-control studies and experimental findings.

Cite

CITATION STYLE

APA

Akbar, S., & Alsharidah, M. S. (2014). Are beta blockers new potential anticancer agents? Asian Pacific Journal of Cancer Prevention. Asian Pacific Organization for Cancer Prevention. https://doi.org/10.7314/APJCP.2014.15.22.9567

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free